Extendicare Inc (EXE)
Toronto Exchange · Canada · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 26.92 |
|---|---|
| 52-week range | 14.26 – 38.98 |
| Return, 1 month / 3 months | −11.8% / −30.3% |
| Return, 1 year / 3 years | +85.4% / +400.7% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 35.2% |
| Worst drawdown (1 year) | -31.1% |
| Average daily value traded | 18.80M CAD |
| Dividend yield | 1.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Extendicare Inc is a Canadian provider of senior care services. The company operates long-term care homes and retirement communities, offering accommodation, nursing and personal care to older adults. Through its home health care division, it also delivers nursing and support services to people in their own homes. Extendicare is based in Markham, Ontario, and serves residents and patients across Canada, working with provincial health systems and families who need continuing care for elderly relatives.
The shares are listed on the Toronto Exchange in Canada under the code EXE, and the price on this page is in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Extendicare Inc (EXE) trades on the Toronto Exchange in Canada. It last closed at CAD 26.92 on 19 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 428 of 868 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 85.4% and over the last three months it fell 30.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 40 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -8.9% | ||
| From 52-week high | -30.3% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -30.3% | ||
| 6-month return | -6.7% | ||
| 12-month return, skipping the last month | 110.1% | ||
| Risk (lower is better) | 54 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 35.2% | ||
| Worst drawdown (1 year) | -31.1% | ||
| Liquidity | 84 · Strong | Trades actively. | |
| Average daily value traded | 18.80M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.9% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +1.0% |
|---|---|
| 1 month | −11.8% |
| 3 months | −30.3% |
| 6 months | −6.7% |
| 1 year | +85.4% |
| 3 years | +400.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 30.22 / 29.54 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.08 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Sep 2026 | CAD 0.0440 |
| 31 Aug 2026 | CAD 0.0440 |
| 31 Jul 2026 | CAD 0.0440 |
| 30 Jun 2026 | CAD 0.0440 |
| 29 May 2026 | CAD 0.0440 |
| 30 Apr 2026 | CAD 0.0440 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.